American pharma giant Pfizer has enlisted the help of technology multinational IBM in an ambitious bid to transform both care and treatment for Parkinson's disease.
Victor Ambros and Gary Ruvkun have shared this year's Nobel Prize in Physiology or Medicine for their discovery of microRNA, a class of RNA molecules that play a crucial role in gene regula